To evaluate the Safety and efficacy of Unani formulations Zimad e Bars in Kalaf (Melasma)

Phase 2

• Conditions: Health Condition 1: L811- ChloasmaHealth Condition 2: null- Kalaf (Melasma)

• Registration Number: CTRI/2015/11/006385
• Lead Sponsor: Central Council for Research in Unani Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 300

Inclusion Criteria

Female Subjects with 18 to 65 years of age

The patient presenting anyone or all signs mentioned below.

1. Ill defined light brown to grey brown macules on Forehead

2. Ill defined light brown to grey brown macules in RMR

3. Ill defined light brown to grey brown macules in LMR

4. Ill defined light brown to grey brown macules on Chin

Exclusion Criteria

Patients with anyone of the following skin disease

•Bahaq Aswad (pitryasis nigra)

oNamash (Naevus).

oBarash (lentigo)

oKhÄ«lÄ?n (mole)

oNishanate Quruh

oFitzpatrick skin type grade 1 & 2

•Any systemic disorder requiring long term treatment.

•Drug or alcohol addict

•Subjects with oral contraceptive pills (OCPs)

•Pregnant and lactating woman

•Those who refuse to avoid cosmetics during study period

Subject Selection

•Female subjects with 18 to 65 years of age

•The patient presenting anyone or all signs mentioned below.

1. Ill defined light brown to grey brown macules on Forehead

2. Ill defined light brown to grey brown macules in RMR

3. Ill defined light brown to grey brown macules in LMR

4. Ill defined light brown to grey brown macules on Chin

Study & Design

• Study Type: Interventional
• Study Design: Not specified